Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin-Reference-Cited by-同舟云学术

Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin

Published:2022 Issue:7 Volume:18 Page:643-651
ISSN:2515-4184
Container-title:Molecular Omics
language:en
Short-container-title:Mol. Omics

Author:

Zhang Yingwei¹^ORCID,Zhang Zeyu²,Li Chundi¹,Tang Donge²,Dai Yong²^ORCID

Affiliation:

1. Department of Neurology, Shenzhen Longhua District Central Hospital, Shenzhen 518000, China

2. The Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen Engineering Research Center of Autoimmune Disease, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen 518020, China

Abstract

Metabolomics screening revealed the alteration of fatty acid oxidation in the hearts of diabetic mice after SGLT2i treatment.

Funder

Shenzhen Technical Project

Publisher

Royal Society of Chemistry (RSC)

Subject

Genetics,Molecular Biology,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/MO/D2MO00036A

Reference35 articles.

1. Precision medicine in the management of type 2 diabetes